Neuralink Successfully Implants Brain Device in Third Patient

Neuralink Corp., the brain-computer interface company founded by Elon Musk, has successfully implanted its device in a third patient, with plans to expand the program significantly in 2025. Musk shared the update during a Las Vegas event streamed on X, his social media platform.

Ad

"We’ve now implanted Neuralinks in three humans, and they’re all functioning well," Musk said, highlighting the company’s progress in developing groundbreaking technology aimed at assisting individuals with neurological conditions. Neuralink plans to perform 20 to 30 additional implants next year as part of its ongoing clinical efforts.

Neuralink is among a growing number of companies exploring brain implant technologies to treat conditions such as paralysis and amyotrophic lateral sclerosis (ALS). These experimental procedures often involve invasive techniques, including opening the skull to place electrodes within brain tissue.

Advertisement

The company’s first patient, Noland Arbaugh, received the device a year ago. Neuralink now has two U.S.-based clinical studies registered with the Food and Drug Administration (FDA). The first, called the Prime Study, aims to allow paralyzed patients to control external devices like computers or smartphones using their thoughts. This study is designed for five participants.

The second study, known as Convoy, focuses on enabling three patients to control assistive devices such as robotic arms through the implanted technology. Both initiatives underscore Neuralink’s ambitious vision of merging human cognition with advanced machine interfaces to improve quality of life for individuals with debilitating conditions.

With these advancements, Neuralink continues to push the boundaries of neuroscience and technology, offering hope for transformative solutions to some of the most challenging medical conditions.

Also Read: Neuralink Successfully Completes Second Brain Implant Surgery